Bid price | 67.00 | Open price | 65.01 |
---|---|---|---|
Ask price | 70.00 | Prev close | 68.50 |
High price | 0.00 | Spread | 4.29% |
Low price | 0.00 | Volume | 0 |
Register now for FREE live Destiny Pharma share prices, Destiny Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Destiny Pharma Level 2 Data, indepth research tools and investor commentary for Destiny Pharma (DEST) and other London Stock Exchange equities.
Register now for FREE Destiny Pharma share price charts
Name | Destiny Pharma | Epic | DEST |
---|---|---|---|
Sector | n/a | ISIN | GB00BDHSP575 |
Activites | n/a | Index | n/a |
Dec.Date | Type | Director | Pos | No. of Shares |
---|---|---|---|---|
05/08/2024 | BUY | Anthony Rudd | RES | 1,240,000 |
19/10/2023 | TIN | Christopher Tovey | CEO | 30,000 |
19/10/2023 | TOUT | Christopher Tovey | CEO | 30,000 |
10/10/2023 | BUY | Christopher Tovey | CEO | 40,000 |
04/10/2023 | TIN | William Love | ED | 2,300,000 |
RNS Number : 1888H Destiny Pharma PLC 01 December 2020 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS...
Debra Barker, Non Executive Director, received via a placing 38,461 shares in the company on the 27th November 2020 at a price of £0.65. The Director now holds 38,461 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.uk
Neil Clark, Chief Executive Officer, received via a placing 38,462 shares in the company on the 27th November 2020 at a price of £0.65. The Director now holds 38,462 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.uk
More Destiny Pharma Company News >>
Register now for FREE Destiny Pharma company news
No Destiny Pharma Share Price Discussions
Register now for FREE Destiny Pharma share price discussions